Fact CheckerSign in

NCT06049693CompletedPhase 4

Iron Prehabilitation in Endometrial Cancer

Iron Prehabilitation and Perioperative Infectious Diseases of Endometrial Cancer Patients

Source: ClinicalTrials.gov · Last updated 29 Mar 2024

Brief summary (registry, in English)

Endometrial cancer patients often have iron deficiency anemia before surgery, which can be effectively treated with oral iron supplementation. Anemia and blood transfusions have been previously associated with perioperative infectious diseases. In the present study the investigators will evaluate the impact of perioperative iron supplementation on the incidence of perioperative infections.

Status (registry)
Completed
Phase (registry)
Phase 4
Study type
Interventional
Enrollment
156 (actual)
First submitted
25 Apr 2023
Start date
Jan 2023
Primary completion date
Jan 2024
Lead sponsor
National and Kapodistrian University of Athens
NCT number
NCT06049693

What you commit to

  • Study type: Interventional · Phase 4
  • Participants enrolled: 156
  • From Jan 2023 to the primary completion date, Jan 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Women with endometrial cancer requiring immediate surgery due to life-threatening hemorrhage

Who the study is looking for

  • Women with endometrial cancer enrolled in the surgical list

Age in the registry: 18 years to 79 years · Sex: Female · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
First department of Obstetrics and Gynecology
Coordinator of this site? Confirm its status
AthensGreeceUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.